跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVOGAM normal immunoglobulin (human) 16% w/v, 1.6g/10mL injection solution vial for subcutaneous use - TGA Drug Approval Details
Approvals
/
TGA
/
EVOGAM normal immunoglobulin (human) 16% w/v, 1.6g/10mL injection solution vial for subcutaneous use
Approved
STANDARD
EVOGAM normal immunoglobulin (human) 16% w/v, 1.6g/10mL injection solution vial for subcutaneous use
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
4575cc65a3b77bc8
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
4575cc65a3b77bc8
Product Name
EVOGAM normal immunoglobulin (human) 16% w/v, 1.6g/10mL injection solution vial for subcutaneous use
Artg Id
173323
Artg Name
EVOGAM normal immunoglobulin (human) 16% w/v, 1.6g/10mL injection solution vial for subcutaneous use
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2012-03-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/21c6ddc82381ed5e26e8078ef99bedca.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9e2ea6ace214df5c3c2fabb0642e86b2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
4575cc65a3b77bc8
Type
Standard
Back to TGA Approvals